Table 1

Health state utility values for the base-case analysis

Health stateUsual care armIntervention arm
Moderate NPDR/severe NPDR0.79150.7915
Severe NPDR and CSDMO0.73650.7365
Early PDR/high-risk PDR/severe PDR0.70470.7047
Early PDR and CSDMO/high-risk PDR and CSDMO/severe PDR and CSDMO0.69300.6930
Severe NPDR PT0.7915
Severe NPDR and CSDMO PT0.7365
Early PDR PT0.7047
Early PDR and CSDMO PT0.6930
High-risk PDR PT/severe PDR PT0.70470.7047
High-risk PDR and CSDMO PT/severe PDR and CSDMO PT0.69300.6930
Severe visual loss/blindness0.62180.6218
  • CSDMO, clinically significant diabetic macular oedema; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; PT, post-treatment.